Amarin Corp Plc (AMRN)

[ziploc_1]

Singer did not give enough emphasis in his brief and oral argument to the cropping of the bottom of the Kura table...Since this very important incident should have been picked up by Covington...(and not doing so was malpractice)...Singer did not want to burden his friends and colleagues at Covington with having to defend a malpractice suit...Without this cropping of Kura, the outcome of the patent suit would have been very different...In judge Du's brief, the "obviousness" of Apo B being lowered by EPA was critical in the Prima Facie evidence, which she based her decision on.